ReviewEye (London, England)2025

New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway.

Sobha Sivaprasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.